7/24/2014 - 11:45 AM EST - Valeant Pharmaceuticals International, Inc. : announced today that it has filed a detailed complaint with the Autorite des marches financiers regarding Allergan, Inc.'s apparent attempts to mislead investors and to negatively influence the market price of Valeant's common shares by continuing to make false and misleading statements regarding Valeant's business despite Valeant's public statements correcting this misinformation. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading up $0.95 at $134.67.
